Two mobile health plans for high blood pressure after childbirth
Compares two app-based plans for managing high blood pressure in adults after giving birth.
Plain-language title generated from the registry record
Registry title: Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
Key facts
- Where
- Columbus, New York, and Philadelphia, United StatesSee the 3 sites
Where in United States
- The Ohio State UniversityColumbus, United StatesNot yet recruiting
- NYU Langone HealthNew York, United StatesTaking people
- University of PennsylvaniaPhiladelphia, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jennifer Lewey, MD, MPH
- Trial code
- NCT07209254
- Record updated
- 22 May 2026
- Original description
A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's healthRead full original descriptionShow less
Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's health
Inclusion: Age ≥18 years; Delivery within 14 days; Diagnosis of preeclampsia or gestational hypertension with or without severe features during pregnancy or within 14 days postpartum; Initiation of blood pressure medication prior to hospital discharge and up to 14 days postpartum; English or Spanish speaking (able to read/understand consent and instructions); Has phone texting capabilities.
Exclusion: Diagnosis of chronic hypertension prior to delivery (would therefore include super imposed preeclampsia); Using ≥3 BP medications at time of enrollment; Chronic kidney disease (stage 3 or higher); Pre-existing cardiovascular disease (including prior myocardial infarction, stroke, heart failure with reduced ejection fraction, ventricular tachycardia, prior cardiac arrest, pacemaker, severe valvular heart disease, or prior cardiac surgery).